GE HealthCare Technologies Inc (GEHC)

NASDAQ
Currency in USD
92.21
-1.27(-1.36%)
Closed
After Hours
92.210.00(0.00%)
GEHC Scorecard
Full Analysis
11 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
91.1893.21
52 wk Range
74.5194.80
Key Statistics
Edit
Prev. Close
93.48
Open
93.2
Day's Range
91.18-93.21
52 wk Range
74.51-94.8
Volume
3.95M
Average Volume (3m)
3M
1-Year Change
7.2%
Book Value / Share
18.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GEHC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
99.46
Upside
+7.86%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

GE HealthCare Technologies Inc Company Profile

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women’s health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GE HealthCare Technologies Inc Earnings Call Summary for Q4/2024

  • Q4 revenue reached $5.3B with 2% organic growth; full-year revenue hit $19.7B. Adjusted EPS rose 23% YoY to $1.45 in Q4
  • Stock surged 6.05% post-earnings; company introduced 40 innovations in 2024, enhancing AI capabilities
  • 2025 guidance: 2-3% revenue growth, adjusted EPS $4.61-$4.75 (3-6% increase). Challenging H1 expected in China
  • Free cash flow declined $161M YoY to $1.6B in 2024; company continues investing in R&D and strategic acquisitions
  • CEO emphasized innovation strategy and solid performance in revenue, margin, earnings, and cash
Last Updated: 14/02/2025, 01:56 am
Read Full Transcript

Compare GEHC to Peers and Sector

Metrics to compare
GEHC
Peers
Sector
Relationship
P/E Ratio
21.2x34.1x−0.7x
PEG Ratio
0.490.060.00
Price/Book
5.0x2.3x2.6x
Price / LTM Sales
2.1x2.0x3.1x
Upside (Analyst Target)
11.7%75.1%47.6%
Fair Value Upside
Unlock22.5%7.7%Unlock

Analyst Ratings

13 Buy
7 Hold
1 Sell
Ratings:
21 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 99.46
(+7.86% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.37
Dividend Yield
0.15%
Industry Median 0.73%
Annualised payout
0.1400
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 30, 2024
EPS / Forecast
1.14 / 1.05
Revenue / Forecast
4.86B / 4.87B
EPS Revisions
Last 90 days

People Also Watch

121.84
GL
-1.38%
142.50
OLED
-0.84%
193.44
IQV
-1.33%
68.06
CE
+4.23%

FAQ

What Is the GE HealthCare (GEHC) Stock Price Today?

The GE HealthCare stock price today is 92.21

What Stock Exchange Does GE HealthCare Trade On?

GE HealthCare is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for GE HealthCare?

The stock symbol for GE HealthCare is "GEHC."

Does GE HealthCare Pay Dividends? What’s The Current Dividend Yield?

The GE HealthCare dividend yield is 0.15%.

What Is the GE HealthCare Market Cap?

As of today, GE HealthCare market cap is 42.17B.

What is GE HealthCare Earnings Per Share?

The GE HealthCare EPS is 4.37.

From a Technical Analysis Perspective, Is GEHC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.